Orum Therapeutics to Participate in NDR Hosted by Mirae Asset

Written By Allen (Biho) Seo

Orum Therapeutics will participate in a Non-Deal Roadshow (NDR) hosted by Mirae Asset Securities. During this event, the company will hold one-on-one meetings with institutional investors from September 1-3 (KST), introducing the company's proprietary Degrader-Antibody Conjugate (DAC) platform and strategic business initiatives.

Allen (Biho) Seo
Next

Advancing ORM-1153 into the Clinic: Conference Call on IND Clearance & Clinical Study Overview